Monashee Investment Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
CAM
RIM
Monashee Investment Management's LMAT Position: Q1 2025 in Review
Monashee Investment Management sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 40,000 shares — an estimated $3.69M sold.
Monashee Investment Management first reported a position in LMAT in Q4 2024 and held it in 1 quarter. The position peaked at $3.69M in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.
- Monashee Investment Management reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
- Monashee Investment Management sold 40,000 LeMaitre Vascular shares in Q1 2025, an estimated $3.69M.
- Monashee Investment Management first reported a position in LeMaitre Vascular in Q4 2024 and held it in 1 quarter.
- Monashee Investment Management's LeMaitre Vascular position peaked at $3.69M in Q4 2024.
- 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.
Based on Monashee Investment Management's 13F filing for Q1 2025, filed 14 May 2025.